🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2026-525788-42-00
Authorised Phase I

Thorough QT/QTc study with GLPG3667, placebo, and active comparator in healthy subjects

2026-525788-42-00 · tracked via the Priya Life Science EU tracker
Sponsor
Galapagos
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
22/05/2026
Enrollment target
25
Sites
Netherlands

Condition studied

Healthy volunteers

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525788-42-00 on CTIS ↗ ← All trials in the EU